Libra Infusions (DHA:LIBRAINFU) Other Stockholders Equity: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT661.40
View Full Analysis

What is Libra Infusions Other Stockholders Equity?

Libra Infusions DHA:LIBRAINFU 21 Other Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100.

Libra Infusions's Other Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil.

Libra Infusions Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Other Stockholders Equity Chart

Libra Infusions Annual Data
Trend
Other Stockholders Equity

Libra Infusions Semi-Annual Data
Other Stockholders Equity
DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of BDT0.00 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Other Stockholders Equity of BDT0.00 Mil as of . 20. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' Other Stockholders Equity too high?
Libra Infusions' current Other Stockholders Equity is BDT0.00 Mil. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Other Stockholders Equity compare to SECI and LENSF?
Libra Infusions' Other Stockholders Equity of BDT0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Libra Infusions and its competitors. Libra Infusions's current Other Stockholders Equity is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Other Stockholders Equity of BDT0.00 Mil. The current Other Stockholders Equity is BDT0.00 Mil. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Other Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT661.40
Price